Sanjay Chandra
Executive Officer at Trinity Nuclein Series C QP Investors.
Raised on Trinity Nuclein Series C QP Investors filings
$1M
of $15M offered across 1 Form D filing
- Form D filings
- 1
- Teammates
- 1
- Last filing
- Mar 3, 2025
Company
Trinity Nuclein Series C QP Investors
Biotech · Southlake, TX
Investment vehicle backing a rapid PCR test maker
Investment vehicle backing a rapid PCR test maker
- Investors
- 11
- Founded
- 2025
- Still open
- $14M
Trinity Nuclein Series C QP Investors filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Mar 3, 2025 | Equity | $1M/ $15M | Form D |
- EquityFiled Mar 3, 2025Form D$1M/ $15M
